Crescita Therapeutics Overview

  • Status
  • Public
  • Employees
  • 68
Employees
  • Stock Symbol
  • CTX
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $0.67
  • (As of Friday Closing)

Crescita Therapeutics General Information

Description

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The firm generates its revenue in the form of product sales and out-licensing revenue.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Personal Products
Stock Exchange
TSE
Primary Office
  • 7560 Airport Road
  • Unit 10
  • Mississauga, Ontario L4T 4H4
  • Canada
+1 (905) 000-0000

Crescita Therapeutics Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Crescita Therapeutics Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.67 $0.68 $0.28 - $0.80 $13.8M 20.6M 30.6K

Crescita Therapeutics Financials Summary

In Thousands,
USD
TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 1,949 8,958 3,903 2,531
Revenue 12,384 16,828 12,825 9,254
EBITDA 1,784 4,002 1,765 (7,503)
Net Income 108 1,397 1,848 (8,830)
Total Assets 20,762 20,545 20,238 17,944
Total Debt 980 1,185 3,237 3,431
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Crescita Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Crescita Therapeutics‘s full profile, request access.

Request a free trial

Crescita Therapeutics Executive Team (4)

Name Title Board Seat Contact Info
Serge Verreault Chief Executive Officer & President
Jose DaRocha Chief Financial Officer, Finance
You’re viewing 2 of 4 executive team members. Get the full list »

Crescita Therapeutics Board Members (4)

Name Representing Role Since
0000000 00000000000 Self Board Member 000 0000
000000 00000000 Crescita Therapeutics Chairman & Board Member 000 0000
0000 000000 Self Board Member 000 0000
You’re viewing 3 of 4 board members. Get the full list »

Crescita Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Crescita Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Crescita Therapeutics‘s full profile, request access.

Request a free trial

Crescita Therapeutics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 0000 000000 01-Sep-2016 000000000000000000 0000 Pharmaceuticals 00000 000000000
To view Crescita Therapeutics’s complete acquisitions history, request access »

Crescita Therapeutics Subsidiaries (1)

Company Name Industry Location Founded
000000 0000 000000 Pharmaceuticals Laval, Canada 0000
To view Crescita Therapeutics’s complete subsidiaries history, request access »